ONPHOTCHealthcare · Biotechnology

Oncology Pharma Inc.

$0.08-11.11%($-0.01)

TickerSpark Score

42/100

Weak

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ONPH research report →

52-Week Range22% of range

Low $0.00

Current $0.08

High $0.36

Companywww.oncology-pharma.com

Oncology Pharma Inc. , an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc.

CEO: George Malesek
IPO: 1994
Employees: 1
HQ: San Francisco, CA, US

Price Chart

+79900.00% · this period

Valuation

Market Cap: $2.19M
P/E: -1129.41
P/S: 0.00
P/B: 5.27
EV/EBITDA: -489.55
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -1.08%
ROIC: -0.30%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-5,820 · 0.00%
EPS: $0.00 · 0.00%
Op Income: $-5,820
FCF YoY: 0.00%

Performance & Tape

52W High: $0.36
52W Low: $0.00
50D MA: $0.07
200D MA: $0.02
Beta: -3.05
Avg Volume: 57.67K

Get TickerSpark's AI analysis on ONPH

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime